Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Sep 9, 2026, 9:30 AM EST
Biostax Market Cap
Biostax has a market cap or net worth of $21.53 thousand as of September 10, 2026. Its market cap has increased by 24.70% in one year.
Market Cap
21.53K
Enterprise Value
1.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 14, 2012, Biostax's market cap has decreased from 377.40K to 21.53K, a decrease of -94.30%. That is a compound annual growth rate of -18.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 21.53K | -98.39% |
| Dec 31, 2024 | 1.34M | -78.10% |
| Dec 28, 2023 | 6.11M | -87.74% |
| Dec 30, 2022 | 49.83M | 3,358.09% |
| Dec 30, 2021 | 1.44M | -78.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Itoco | 42.82K |
| Carisma Therapeutics | 29.29K |
| Entia Biosciences | 27.25K |
| Nymox Pharmaceutical | 21.01K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| Statera Biopharma | 14.52K |